title: Multiple-system atrophy and medications: how to minimize the risk of falling.
abstract: An 89-year-old female resident in the assisted living section of a continuing care retirement community complained of dizziness and lightheadedness at 10 am daily and was experiencing frequent falls. The facility staff requested a consultant pharmacist perform an extensive review of her medications and medical conditions. Following a chart review and interview with the resident, the consultant pharmacist found that her past medical history consists of coronary artery disease, atrial fibrillation, congestive heart failure, hypertension, dyslipidemia, osteoporosis, gastroesophageal reflux disease, glaucoma, mild dementia, overactive bladder, and Parkinson's disease (PD). The nursing staff monitored the resident's blood pressure during these episodes and determined that the resident was experiencing orthostatic hypotension (OH). During the review, the consultant pharmacist found a recent neurology note that concluded the resident may have multiple-system atrophy (MSA) and her therapy for PD may not be beneficial. As autonomic dysfunction is a common feature of MSA, it is important to minimize the use of medications that can cause or aggravate OH. Additionally, data suggest only a modest and nonsustained response to levodopa in patients with MSA. Therefore, the pharmacist recommended multiple medication changes as well as follow-up monitoring by the patient and assisted living community staff to minimize medication-related problems such as falls.
authors.affiliation: Omnicare Pharmacy Services, Pittsburgh, Pennsylvania 15205, USA. janet.mahoney@omnicare.com
authors.forename: Janet
authors.initials: J
authors.lastname: Kohli
authors.forename: Nicole
authors.initials: N
authors.lastname: Brandt
mesh_terms: D000058:Accidental Falls / Q000517:prevention & control*; D000369:Aged, 80 and over; D000978:Antiparkinson Agents / Q000627:therapeutic use; D040561:Assisted Living Facilities; D001342:Autonomic Nervous System Diseases / Q000150:complications / Q000209:etiology*; D003253:Consultants; D005260:Female; D006801:Humans; D007024:Hypotension, Orthostatic / Q000150:complications / Q000209:etiology*; D019578:Multiple System Atrophy / Q000150:complications* / Q000503:physiopathology; D010300:Parkinson Disease / Q000188:drug therapy; D010595:Pharmacists / Q000458:organization & administration
chemical_list: D000978:Antiparkinson Agents